Latest Articles

Home Sleep Monitoring Opens Gateway for Better Apnea Control

By Lee A. Surkin MD, FACC, FCCP | Contributing Writer - Vol. 10, No. 1. Spring, 2009

Sleep apnea is common, debilitating and sometimes deadly. In the past, diagnosis involved costly sleep labs. New home monitoring devices provide greater patient comfort, save money, and generate revenue for primary care. Dr. Lee Surkin shares his clinical experience.

JUPITER: Separating the Solid Clinical Matter From the Hot Gas

By August West | Contributing Writer - Vol. 9, No. 4. Winter, 2008

Gaseous Surface of Jupiter: Many cardiologists are hailing the massive JUPITER trial as a breakthrough, claiming that statin therapy could reduce cardiovascular risk even in patients with normal LDL.

IDA Medical Foundation Seeks to "Democratize" Prevention

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.

GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

"NO" News is Good News: Nitric Oxide for CVD & Diabetes

By Tamara Sofi-Smith, PhD candidate | Contributing Writer - Vol. 9, No. 4. Winter, 2008

"From diabetes to hypertension, cancer to drug addiction, stroke to intestinal motility, memory and learning disorders to septic shock, sunburn to anorexia, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role."

Chronic Fatigue, Cardiomyopathy & Oxidative Stress: New Thinking Opens New Approaches

By Allison Templet | Contributing Writer - Vol. 9, No. 3. Fall, 2008

Chronic fatigue syndrome (CFS), one of the most vexing conditions for patients and doctors alike, reflects a state of oxygen toxicity, and management of oxidative stress appears to be a key to reversing the fatigue, pain, and neuropsychological complaints associated with this disorder, says Paul R. Cheney, MD, PhD, a pioneer in the clinical research of CFS.

Metabolic Cardiology: Solving the Heart's Energy Crisis

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 2. Summer, 2008

A new vanguard of "metabolic" cardiologists contends that cholesterol elevation has been overstated as a cause of heart disease, and that physicians should pay more attention to the heart muscle itself. A quartet of nutrients magnesium, co-enzyme Q10, L-carnitine, and D-ribose can profoundly improve the heart's pumping ability and reduce risk of death, even in very ill patients.

HPC Readers Boost TACT Trial Enrollment

By Staff Writer - Vol. 9, No. 2. Summer, 2008

Readers of Holistic Primary Care are giving a big boost to the Trial to Assess Chelation Therapy (TACT), a landmark NIH study to determine whether chelation therapy can prevent heart attacks. After reading about the ongoing trial in our Spring 2008 edition, 17 physician readers called the study's headquarters in Miami Beach, seeking to enroll their clinics as study sites.

Oximation in Practice: Clearing Acne & Related Skin Disorders

By Roby Mitchell, MD | Contributing Writer - Vol. 10, No. 2. Summer, 2009

Acne, psoriasis, rosacea and other common skin disorders are reflections of the same systemic inflammatory processes that underlie heart disease, diabetes, irritable bowel, and many other chronic disorders. Eliminating high-glycemic foods, restoring hormone balance, and minimizing inflammation will not only resolve these skin problems, they will also reduce risk of more serious diseases along the way.

ASU & Pycnogenol Join Glucosamine on Frontline of Natural Arthritis Therapies

By Erik L. Goldman | Editor-in-Chief - Vol. 10, No. 2. Summer, 2009

Pycnogenol, an extract of French Maritime Pine bark, and Avocado-Soybean Unsaponifiables (ASU), compounds extracted from soy and avocado oils, work as well or better than available anti-arthritic medications. They also have fewer side effects and cost less.